Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 431

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 431
---
 and Bioceres S.A., an affiliate of Bioceres Group PLC, entered into a revolving loan agreement in the aggregate amount of up to $460,000, which was made available in Argentine Pesos, for working capital and general corporate purposes, available for disbursement through January 17, 2024. On May 19, 2023, the parties executed an amendment to increase the facility amount to up to $720,000. On March 19, 2024 the maturity of this agreement was extended to January 17, 2028 and accrues interest at 6.5% per annum. The outstanding balance of this loan as of June30, 2024 was $267,066. On October23, 2024, the parties executed an amendment to increase the facility amount to up to $820,000. On March18, 2025, the parties executed an amendment to increase the facility amount to up to $1,000,000. On September 1, 2023, Heritas Argentina, Theo and Bioceres S.A., an affiliate of Bioceres Group PLC, entered into a revolving loan agreement in the aggregate amount of up to $157,143 which was made available in Argentine Pesos, and is available for disbursement through September 1, 2024. The outstanding balance of this loan as of June 30, 2024 was $22,118. On April 18, 2024 the maturity of this agreement was extended to September 1, 2028 and accrues interest at 6.5% per annum. On January 17, 2023, Heritas Argentina and CIBIC entered into a revolving loan agreement in the aggregate amount of up to $1,006,686, which was made available in Argentine Pesos, for working capital and general corporate purposes, and is available for disbursement through January 17, 2024. On January 31, 2023, the parties executed an amendment to adjust certain commercial conditions. On October 23, 2023, the parties executed an amendment to increase the facility amount to up to $1,106,686. The outstanding balance of this loan as of June 30, 2024 was $127,190. On April 18, 2024 the maturity of this agreement was extended to January 17, 2028 and accrues interest at 6.5% per annum. On October 1, 2023,